Active substanceCocarboxylaseCocarboxylase
Similar drugsTo uncover
  • Cocarboxylase
    lyophilizate w / m in / in 
    Company DEKO, LLC     Russia
  • Cocarboxylase
    lyophilizate w / m 
  • Cocarboxylase
    lyophilizate w / m in / in 
  • Cocarboxylase
    lyophilizate w / m in / in 
  • Cocarboxylase-Ferein
    lyophilizate w / m in / in 
    BRYNTSALOV-A, CJSC     Russia
  • Cocarboxylase-Ellara®
    lyophilizate w / m in / in 
    ELLARA, LTD.     Russia
  • Cocarboxylase hydrochloride
    lyophilizate w / m in / in 
  • Dosage form: & nbsp

    lyophilizate for the preparation of a solution for intramuscular administration.

    Composition:

    Composition per 1 ampoule:

    Active substance: cocarboxylase hydrochloride - 50 mg; auxiliary substances: sodium carbonate - 8 mg.

    Description:

    Lyophilized powder or dry porous hygroscopic mass of white with a characteristic odor.

    Pharmacotherapeutic group:Metabolic means
    ATX: & nbsp

    A.11.D.A   Vitamin B1

    Pharmacodynamics:

    Kokarboksilaza - coenzyme thiamine (vitamin B1), has a metabolic effect, activates tissue metabolism. In the body it is phosphorylated to form mono-, di- and triphosphoric esters; cocarboxylase is part of the enzymes that catalyze the carboxylation and decarboxylation of keto acids, pyruvic acid, promotes the formation of acetyl-coenzyme A, which determines its participation in carbohydrate metabolism. Participation in the Krebs cycle indirectly promotes the synthesis of nucleic acids, proteins and lipids. Exogenous vitamin B1 (thiamine) to participate in these processes should phosphorylation of the metabolite in the cocarboxylase is a ready-made form of coenzyme. It should be noted that the properties of cocarboxylase are only partially adequate to those of thiamine; cocarboxylase is not used for the prevention and treatment of hypo- and avitaminosis B1.

    Kokarboksilaza improves the absorption of glucose, trophic nervous tissue, contributes to the normalization of the functions of the cardiovascular system. Deficiency of cocarboxylase causes an increase in the level of pyruvic and lactic acids in the blood, which leads to acidosis and an acidotic coma.

    Indications:

    The cocarboxylase is prescribed in complex therapy:

    - diabetic precoma and coma;

    - diabetic ketoacidosis;

    - chronic heart failure and heart rhythm disturbances;

    - peripheral neuritis.

    Children prescribe the drug for the same indications.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Pregnancy and lactation:The use of the drug during pregnancy and lactation is possible if the intended benefit to the mother exceeds the potential risk to the fetus and the baby.
    Dosing and Administration:

    Intramuscularly. The contents of the ampoule immediately before use are dissolved in 2 ml of water for injection.

    When heart diseases are administered for 100-200 mg / day for 15-30 days.

    In diabetes mellitus (acidosis, coma) the daily dose is 100 mg.

    With peripheral neuritis - intramuscularly, in a dose of 50-100 mg / day for 1-1.5 months.Children are administered intramuscularly. Depending on the severity of the condition and clinical symptoms, it is prescribed from 25 to 50 mg per day. The course of treatment is from 3-7 to 15-30 days.

    Side effects:

    Allergic reactions (hives, itching), with intramuscular injection - hyperemia, itching, swelling (at the injection site).

    Interaction:

    Kokarboksilaza increases the cardiotonic action of cardiac glycosides and improves their tolerability.

    Form release / dosage:

    Lyophilizate for the preparation of solution for intramuscular injection 50 mg.

    Packaging:

    The drug is placed in ampoules with a capacity of 5 ml of neutral glass.2 ml of water for injection are placed in ampoules of neutral glass.

    5 ampoules with the preparation complete with 5 ampoules of water for injection together with the instruction for use are placed in a pack with a corrugated cardboard insert. In each pack, the scriber is inserted ampoule.

    5 ampoules of the drug are placed in a contoured cell pack of a polyvinyl chloride film.

    1 or 2 contour mesh packages together with the instruction for use and the ampoule scarifier are put in a pack of cardboard. When using ampoules with a notch, dot or ring fracture, the scarifier is not inserted.

    Storage conditions:

    Store in a dark place at a temperature of no higher than 10 ° C. Keep out of the reach of children.

    Shelf life:

    3 years.

    Terms of leave from pharmacies:On prescription
    Registration number:P N002476 / 01
    Date of registration:09.09.2008 / 04.10.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp30.01.2018
    Illustrated instructions
      Instructions
      Up